Facebook Linkedin RSS Twitter Youtube
Home 2023

Colitis

Abivax Advances Ulcerative Colitis Candidate with U.S. IPO
Drug Discovery

Abivax Advances Ulcerative Colitis Candidate with U.S. IPO

Roche to Acquire Telavant for Up-to-$7.25B, Adding IBD Antibody
Drug Discovery

Roche to Acquire Telavant for Up-to-$7.25B, Adding IBD Antibody

StockWatch: Novo Nordisk Shares Soar as Ozempic Aces Phase III CKD Trial
Drug Discovery

StockWatch: Novo Nordisk Shares Soar as Ozempic Aces Phase III CKD Trial

Colon Cancer Accelerated by Age-Related Changes in Blood System
Cancer

Colon Cancer Accelerated by Age-Related Changes in Blood System

Peptides Developed to Diagnose Common Inflammatory Diseases
News

Peptides Developed to Diagnose Common Inflammatory Diseases

Merck to Acquire Prometheus Biosciences for $10.8B
Drug Discovery

Merck to Acquire Prometheus Biosciences for $10.8B

Pivotal Years: Abivax’s Obefazimod Faces Phase III Test
Drug Discovery

Pivotal Years: Abivax’s Obefazimod Faces Phase III Test

Metastatic Colorectal Cancers in Mice Virtually Eliminated Using Immunotherapy and Experimental Drug Combo
Cancer

Metastatic Colorectal Cancers in Mice Virtually Eliminated Using Immunotherapy and Experimental Drug Combo

StockWatch: Summit Nearly Triples on Up-to-$5B Cancer Alliance with Akeso
Cancer

StockWatch: Summit Nearly Triples on Up-to-$5B Cancer Alliance with Akeso

Inflammatory Bowel Disease Healing Hindered by Immune Cells
News

Inflammatory Bowel Disease Healing Hindered by Immune Cells

123...9Page 2 of 9
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.